A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01337661|
Recruitment Status : Completed
First Posted : April 19, 2011
Last Update Posted : August 28, 2012
|Condition or disease|
|Chronic Obstructive Pulmonary Disease|
|Study Type :||Observational|
|Actual Enrollment :||26 participants|
|Official Title:||An Exploratory Study of the Cellular Inflammatory Mechanisms Associated With Chronic Obstructive Pulmonary Disease Exacerbations|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||January 2012|
|Actual Study Completion Date :||February 2012|
Adult male and female subjects with COPD
- Identification of how inflammatory pathways differ in COPD subjects [ Time Frame: 6 weeks ]Identify how inflammatory pathways differ in subjects with COPD during an acute exacerbation relative to when the disease is stable.
- Biomarker Sample Repository [ Time Frame: 6 weeks ]Establish a biomarker sample repository to support future target validation for the treatment of subjects with COPD.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01337661
|Dublin, Ireland, 15|
|Study Director:||Rene van der Merwe, MBChB, MFPM||MedImmune Ltd|
|Principal Investigator:||Prof. Connor Burke||BCF Diagnostics|